Abstract: The invention provides a human Nek1-related protein kinase (NRPK) and polynucleotides which identify and encode NRPK. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of NRPK.
Type:
Grant
Filed:
January 11, 2000
Date of Patent:
March 30, 2004
Assignee:
Incyte Corporation
Inventors:
Olga Bandman, Neil C. Corley, Karl J. Guegler, Mariah Baughn